FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W114590483> ?p ?o ?g. }

• W114590483 endingPage "856" @default.
• W114590483 startingPage "849" @default.
• W114590483 abstract "The primary phase of ADP-induced aggregation of human platelets does not involve appreciable formation of thromboxane A2 or release of granule contents; lack of formation of inositol trisphosphate has also been noted. Because these responses of platelets to ADP differ so markedly from their responses to other aggregating agents, the roles in ADP-induced aggregation of diacylglycerol, protein kinase C, increases in cytosolic [Ca2+], phosphorylation of pleckstrin (47 kDa) and phosphatases 1 and 2a were investigated. Washed human platelets, prelabelled with [14C]5-hydroxytryptamine and suspended in Tyrode solution (2 mM Ca2+, 1 mM Mg2+), were used for comparisons between the aggregation induced by 2-4 microM ADP, in the presence of fibrinogen, and that induced by 0.05 units/ml thrombin. The diacylglycerol kinase inhibitor 6-(2-[(4-fluorophenyl)phenyl-methylene]-1-piperidinylethyl)-7-meth yl-5H-thiazolo[3,2-a]-pyrimidin-5-one (R59022; 25 microM) had no, or only a slight, enhancing effect on ADP-induced aggregation, but potentiated thrombin-induced responses to a much greater extent. 1,2-Dihexanoyl-sn-glycerol or 1-oleoyl-2-acetyl-sn-glycerol (25 microM) added with or 30-90 s before ADP greatly potentiated aggregation without formation of thromboxane; staurosporine, an inhibitor of protein kinase C, reduced this potentiation. Staurosporine (25 nM) did not inhibit ADP-induced aggregation, although it strongly inhibited thrombin-induced aggregation and release of [14C]5-hydroxytryptamine. All these observations indicate little or no dependence of primary ADP-induced aggregation on the formation of diacylglycerol or on the activation of protein kinase C. At 2-4 microM, ADP did not significantly increase the phosphorylation of pleckstrin (studied with platelets prelabelled with [32P]orthophosphate), but 1,2-dihexanoyl-sn-glycerol- induced phosphorylation of pleckstrin was increased by ADP. Surprisingly, the diacylglycerols strongly inhibited the ADP-induced rise in cytosolic [Ca2+] concurrently with potentiation of ADP-induced aggregation; thus the extent of primary aggregation is independent of the level to which cytosolic [Ca2+] rises. Incubation of platelets with 1,2-dihexanoyl-sn-glycerol or 1-oleoyl-2-acetyl-sn-glycerol for several minutes reversed their potentiating effects on aggregation, and inhibition was observed. Incubation of platelets with okadaic acid, an inhibitor of phosphatases 1 and 2a, inhibited ADP- and thrombin-induced aggregation; although the reason for this effect is unknown, it is unlikely to involve inhibition of phospholipase C, since formation of diacylglycerol appears to have little involvement in the primary phase of ADP-induced aggregation." @default.
• W114590483 created "2016-06-24" @default.
• W114590483 creator A5008612050 @default.
• W114590483 creator A5014694278 @default.
• W114590483 creator A5025275101 @default.
• W114590483 creator A5054161448 @default.
• W114590483 date "1993-03-15" @default.
• W114590483 modified "2023-10-18" @default.
• W114590483 title "Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid" @default.
• W114590483 cites W1029812605 @default.
• W114590483 cites W1419842611 @default.
• W114590483 cites W147246515 @default.
• W114590483 cites W1516827029 @default.
• W114590483 cites W1521493025 @default.
• W114590483 cites W1523319406 @default.
• W114590483 cites W1533126363 @default.
• W114590483 cites W1545190048 @default.
• W114590483 cites W156869669 @default.
• W114590483 cites W1577019207 @default.
• W114590483 cites W1822167571 @default.
• W114590483 cites W1891400074 @default.
• W114590483 cites W1966653630 @default.
• W114590483 cites W1970078269 @default.
• W114590483 cites W1974538311 @default.
• W114590483 cites W1980180619 @default.
• W114590483 cites W2005902831 @default.
• W114590483 cites W2014316425 @default.
• W114590483 cites W2014506050 @default.
• W114590483 cites W2018289835 @default.
• W114590483 cites W2020472500 @default.
• W114590483 cites W2023786202 @default.
• W114590483 cites W2024208090 @default.
• W114590483 cites W2028642327 @default.
• W114590483 cites W2036996259 @default.
• W114590483 cites W2038510313 @default.
• W114590483 cites W2040547747 @default.
• W114590483 cites W2066718775 @default.
• W114590483 cites W2069164829 @default.
• W114590483 cites W2073950118 @default.
• W114590483 cites W207951093 @default.
• W114590483 cites W2083879217 @default.
• W114590483 cites W2095549701 @default.
• W114590483 cites W2100837269 @default.
• W114590483 cites W2149580070 @default.
• W114590483 cites W2149921595 @default.
• W114590483 cites W2152955688 @default.
• W114590483 cites W2165651249 @default.
• W114590483 cites W2236226837 @default.
• W114590483 cites W2244269125 @default.
• W114590483 cites W2255730152 @default.
• W114590483 cites W2278521824 @default.
• W114590483 cites W2401348581 @default.
• W114590483 cites W2402932612 @default.
• W114590483 cites W2411382576 @default.
• W114590483 cites W2444018437 @default.
• W114590483 doi "https://doi.org/10.1042/bj2900849" @default.
• W114590483 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1132359" @default.
• W114590483 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8384448" @default.
• W114590483 hasPublicationYear "1993" @default.
• W114590483 type Work @default.
• W114590483 sameAs 114590483 @default.
• W114590483 citedByCount "43" @default.
• W114590483 countsByYear W1145904832015 @default.
• W114590483 countsByYear W1145904832020 @default.
• W114590483 crossrefType "journal-article" @default.
• W114590483 hasAuthorship W114590483A5008612050 @default.
• W114590483 hasAuthorship W114590483A5014694278 @default.
• W114590483 hasAuthorship W114590483A5025275101 @default.
• W114590483 hasAuthorship W114590483A5054161448 @default.
• W114590483 hasBestOaLocation W1145904832 @default.
• W114590483 hasConcept C11960822 @default.
• W114590483 hasConcept C170493617 @default.
• W114590483 hasConcept C178666793 @default.
• W114590483 hasConcept C181199279 @default.
• W114590483 hasConcept C184235292 @default.
• W114590483 hasConcept C185592680 @default.
• W114590483 hasConcept C195794163 @default.
• W114590483 hasConcept C203014093 @default.
• W114590483 hasConcept C2776387844 @default.
• W114590483 hasConcept C2776953658 @default.
• W114590483 hasConcept C2777292125 @default.
• W114590483 hasConcept C2777427919 @default.
• W114590483 hasConcept C2778597717 @default.
• W114590483 hasConcept C2779084600 @default.
• W114590483 hasConcept C2909482567 @default.
• W114590483 hasConcept C36020004 @default.
• W114590483 hasConcept C55493867 @default.
• W114590483 hasConcept C86803240 @default.
• W114590483 hasConcept C89560881 @default.
• W114590483 hasConcept C97029542 @default.
• W114590483 hasConceptScore W114590483C11960822 @default.
• W114590483 hasConceptScore W114590483C170493617 @default.
• W114590483 hasConceptScore W114590483C178666793 @default.
• W114590483 hasConceptScore W114590483C181199279 @default.
• W114590483 hasConceptScore W114590483C184235292 @default.
• W114590483 hasConceptScore W114590483C185592680 @default.
• W114590483 hasConceptScore W114590483C195794163 @default.
• W114590483 hasConceptScore W114590483C203014093 @default.

• next